RTTNews | Aug 25, 2020 07:12AM EDT

07:11 Tuesday, August 25, 2020 (RTTNews) - REGENXBIO Says FDA Clearance Of IND For Phase II Trial Of RGX-314 For Diabetic Retinopathy Using Suprachoroidal Delivery

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved